Works by KOOIJ, P. P. M.

Results: 15

Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicle.

Published in:

British Journal of Pharmacology, 1999, v. 126, n. 5, p. 1091, doi. 10.1038/sj.bjp.0702405

By:

Van 't Veen, Annemarie;
Gommers, Diederik;
Verbrugge, Serge J C;
Wollmer, Per;
Mouton, Johan W;
Kooij, Peter P M;
Lachmann, Burkhard

Publication type:

Article

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr³-Octreotide and 177Lu-DOTA0, Tyr³-Octreotate.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 83S

By:

Valkema, Roelf;
Pauwels, Stanislas A.;
Kvols, Larry K.;
Kwekkeboom, Dik J.;
Jamar, Francois;
de Jong, Marion;
Barone, Raffaella;
Walrand, Stephan;
Kooij, Peter P. M.;
Bakker, Willem H.;
Lasher, Janet;
Krenning, Eric P.

Publication type:

Article

Peptide Receptor Radionuclide Therapy for Non--Radioiodine-Avid Differentiated Thyroid Carcinoma.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 107S

By:

Teunissen, Jaap J. M.;
Kwekkeboom, Dik J.;
Kooij, Peter P. M.;
Bakker, Willem H.;
Krenning, Eric P.

Publication type:

Article

Tumor Response After [90Y-DOTA0,Tyr³]- Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size.

Published in:

Journal of Nuclear Medicine, 2001, v. 42, n. 12, p. 1841

By:

de Jong, Marion;
Breeman, Wout A. P.;
Bernard, Bert F.;
Bakker, Willem H.;
Visser, Theo J.;
Kooij, Peter P. M.;
van Gameren, Arthur;
Krenning, Eric P.

Publication type:

Article

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9

By:

Fröberg, Alida C.;
de Jong, Marion;
Nock, Berthold A.;
Breeman, Wout A. P.;
Erion, Jack L.;
Maina, Theodosia;
Verdijsseldonck, Marion;
de Herder, Wouter W.;
van der Lugt, Aad;
Kooij, Peter P. M.;
Krenning, Eric P.

Publication type:

Article

Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1346, doi. 10.1007/s00259-006-0172-9

By:

Esser, J. P.;
Krenning, E. P.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
van Gameren, A. L. H.;
Bakker, W. H.;
Kwekkeboom, D. J.

Publication type:

Article

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 417, doi. 10.1007/s00259-002-1050-8

By:

Kwekkeboom, D. J.;
Bakker, W. H.;
Kam, B. L.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
de Herder, W. W.;
Feelders, R. A.;
van Eijck, C. H. J.;
de Jong, M.;
Srinivasan, A.;
Erion, J. L.;
Krenning, E. P.

Publication type:

Article

Radiotherapy with a Radiolabeled Somatostatin Analogue, [111In-DTPA- d-Phe1]-Octreotide.

Published in:

Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 496, doi. 10.1111/j.1749-6632.1994.tb17300.x

By:

KRENNING, E. P.;
KOOIJ, P. P. M.;
BAKKER, W. H.;
BREEMAN, W. A. P.;
POSTEMA, P. T. E.;
KWEKKEBOOM, D. J.;
OEI, H. Y.;
JONG, M.;
VISSER, T. J.;
REIJS, A. E. M.;
LAMBERTS, S. W. J.

Publication type:

Article

Radiation Dosimetry for Indium-111-Pentetreotide.

Published in:

Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1919

By:

Stabin, M. G.;
Kooij, P. P. M.;
Bakker, W.H.;
Inoue, T.;
Endo, K.;
Coveney, J.;
de Jong, R.;
Minegishi, A.

Publication type:

Article

Effect of Dose and Specffic Activity on Tissue Distribution of Indium-111-Pentetreotide in Rats.

Published in:

Journal of Nuclear Medicine, 1995, v. 36, n. 4, p. 623

By:

Breeman, Wout A. P.;
Kwekkeboom, Dik J.;
Kooij, Peter P. M.;
Bakker, Wilem H.;
Hofland, Leo J.;
Visser, Theo J.;
Ensing, Geert J.;
Lamberts, Steven W. J.;
Krenning, Eric P.

Publication type:

Article

Hepatobiliary Handling of Iodine-125-Tyr³-Octreotide and Indium-111-DTPA-D-Phe¹ Octreotide by Isolated Perfused Rat Liver.

Published in:

Journal of Nuclear Medicine, 1993, v. 34, n. 11, p. 2025

By:

de Jong, Marion;
Bakker, Willem H.;
Breeman, Wout A. P.;
van der Pluijm, Marcel E.;
Kooij, Peter P. M.;
Visser, Theo J.;
Docter, Roelof;
Krenning, Eric P.

Publication type:

Article

Octreotide Scintigraphy for the Detection of Paragangliomas.

Published in:

Journal of Nuclear Medicine, 1993, v. 34, n. 6, p. 873

By:

Kwekkeboom, Dik J.;
van Urk, Hero;
Pauw, Bernard K. H.;
Lamberts, Steven W. J.;
Kooij, Peter P. M.;
Hoogma, Roel P. L. M.;
Krenning, Eric P.

Publication type:

Article

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.

Published in:

Journal of Nuclear Medicine, 1992, v. 33, n. 5, p. 652

By:

Krenning, E. P.;
Bakker, W. H.;
Kooij, P. P. M.;
Breeman, W. A. P.;
Oei, H. Y.;
de Jong, M.;
Reubi, J. C.;
Visser, T. J.;
Bruns, C.;
Kwekkeboom, D. J.;
Reijs, A. E. M.;
van Hagen, P. M.;
Koper, J. W.;
Lamberts, S. W. J.

Publication type:

Article

The Selenium-75-Homocholic Acid Taurine Test Reevaluated: Combined Measurement of Fecal Selenium-75 Activity and 3α-Hydroxy Bile Acids in 211 Patients.

Published in:

Journal of Nuclear Medicine, 1991, v. 32, n. 6, p. 1219

By:

van Tilburg, Antonie J. P.;
de Rooij, Felix W. M.;
den Berg, J. Willem 0. van;
Kooij, Peter P. M.;
van Blankenstein, Mark

Publication type:

Article

Clinical Validation of Fully Automated Computation of Ejection Fraction from Gated Equilibrium Blood-Pool Scintigrams.

Published in:

Journal of Nuclear Medicine, 1983, v. 24, n. 12, p. 1099

By:

Reiber, Johan H. C.;
Lie, Swan Peng;
Simoons, Maarten L.;
Hoek, Cees;
Gerbrands, Jan J.;
Wijns, William;
Bakker, Willem H.;
Kooij, Peter P. M.

Publication type:

Article

Works by KOOIJ, P. P. M.

Lung clearance of intratracheally instilled <sup>99m</sup>Tc-tobramycin using pulmonary surfactant as vehicle.

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with <sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³-Octreotide and <sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³-Octreotate.

Peptide Receptor Radionuclide Therapy for Non--Radioiodine-Avid Differentiated Thyroid Carcinoma.

Tumor Response After [<sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³]- Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size.

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.

Comparison of [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate and [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotide: which peptide is preferable for PRRT?

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In-DTPA- d-Phe<sup>1</sup>]-Octreotide.

Radiation Dosimetry for Indium-111-Pentetreotide.

Effect of Dose and Specffic Activity on Tissue Distribution of Indium-111-Pentetreotide in Rats.

Hepatobiliary Handling of Iodine-125-Tyr³-Octreotide and Indium-111-DTPA-D-Phe¹ Octreotide by Isolated Perfused Rat Liver.

Octreotide Scintigraphy for the Detection of Paragangliomas.

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.

The Selenium-75-Homocholic Acid Taurine Test Reevaluated: Combined Measurement of Fecal Selenium-75 Activity and 3α-Hydroxy Bile Acids in 211 Patients.

Clinical Validation of Fully Automated Computation of Ejection Fraction from Gated Equilibrium Blood-Pool Scintigrams.